ZA794294B - Enzyme derivatives for use in the treatment of venous thrombosis - Google Patents
Enzyme derivatives for use in the treatment of venous thrombosisInfo
- Publication number
- ZA794294B ZA794294B ZA00794294A ZA794294A ZA794294B ZA 794294 B ZA794294 B ZA 794294B ZA 00794294 A ZA00794294 A ZA 00794294A ZA 794294 A ZA794294 A ZA 794294A ZA 794294 B ZA794294 B ZA 794294B
- Authority
- ZA
- South Africa
- Prior art keywords
- treatment
- venous thrombosis
- enzyme derivatives
- enzyme
- derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6424—Serine endopeptidases (3.4.21)
- C12N9/6435—Plasmin (3.4.21.7), i.e. fibrinolysin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D307/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
- C07K14/3153—Streptokinase
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6424—Serine endopeptidases (3.4.21)
- C12N9/6456—Plasminogen activators
- C12N9/6462—Plasminogen activators u-Plasminogen activator (3.4.21.73), i.e. urokinase
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/96—Stabilising an enzyme by forming an adduct or a composition; Forming enzyme conjugates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
- C12Y304/21—Serine endopeptidases (3.4.21)
- C12Y304/21007—Plasmin (3.4.21.7), i.e. fibrinolysin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
- C12Y304/21—Serine endopeptidases (3.4.21)
- C12Y304/21073—Serine endopeptidases (3.4.21) u-Plasminogen activator (3.4.21.73), i.e. urokinase
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Gastroenterology & Hepatology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Enzymes And Modification Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB7835960 | 1978-09-07 |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA794294B true ZA794294B (en) | 1980-08-27 |
Family
ID=10499512
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA00794294A ZA794294B (en) | 1978-09-07 | 1979-08-16 | Enzyme derivatives for use in the treatment of venous thrombosis |
Country Status (17)
Country | Link |
---|---|
US (2) | US4285932A (de) |
EP (1) | EP0009879B1 (de) |
JP (3) | JPS5537198A (de) |
AR (1) | AR220575A1 (de) |
AU (1) | AU524295B2 (de) |
CA (1) | CA1134295A (de) |
DE (1) | DE2966301D1 (de) |
DK (1) | DK160996C (de) |
ES (1) | ES483888A0 (de) |
HK (1) | HK65986A (de) |
HU (1) | HU182458B (de) |
IE (1) | IE48478B1 (de) |
IL (1) | IL58079A0 (de) |
LU (1) | LU88326I2 (de) |
MY (1) | MY8500995A (de) |
NZ (1) | NZ191320A (de) |
ZA (1) | ZA794294B (de) |
Families Citing this family (39)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NZ191320A (en) * | 1978-09-07 | 1982-09-14 | Beecham Group Ltd | In vivo fibrinolytic enzyme having active site blocked by hydrolytically removable group pharmaceutical compositions |
JPS55167275A (en) * | 1979-06-15 | 1980-12-26 | Kowa Co | Preparation of amidinophenyl ester derivative |
EP0028489B1 (de) * | 1979-11-05 | 1983-10-05 | Beecham Group Plc | Enzym-Derivate und ihre Herstellung |
FR2500825B1 (fr) * | 1981-02-27 | 1985-08-23 | Torii & Co Ltd | Nouveau carboxylate de 4-amidino-phenyle substitue, son procede de preparation et agent anti-complement en comprenant |
IT1170913B (it) * | 1981-04-23 | 1987-06-03 | Manetti & Roberts Italo Brit | Procedimento per la produzione di un principio attivo fibrinolitico vasale prodotto enzimatico specifico angiochinasi cosi' ottenuto e sue applicazioni farmaceutiche |
DE3361610D1 (en) * | 1982-04-07 | 1986-02-06 | Beecham Group Plc | Enzyme derivatives, process for preparing them and pharmaceutical compositions containing them |
EP0125269A1 (de) * | 1982-11-11 | 1984-11-21 | Beecham Group Plc | Pharmazeutisch aktive verbindungen |
US4536391A (en) * | 1982-11-17 | 1985-08-20 | Otsuka Pharmaceutical Co. | Process for preparing urokinase complex |
GB8319538D0 (en) * | 1983-07-20 | 1983-08-24 | Beecham Group Plc | Compounds |
JPS60136520A (ja) * | 1983-12-23 | 1985-07-20 | Otsuka Pharmaceut Co Ltd | フイブリン吸着性ウロキナ−ゼ複合体 |
GB8609948D0 (en) * | 1986-04-23 | 1986-05-29 | Beecham Group Plc | Compounds |
GB8334499D0 (en) * | 1983-12-24 | 1984-02-01 | Beecham Group Plc | Derivatives |
GB8334498D0 (en) * | 1983-12-24 | 1984-02-01 | Beecham Group Plc | Compounds |
US4880776A (en) * | 1983-12-24 | 1989-11-14 | Beecham Group P.L.C. | Plasmin A-chain urokinase B-chain hybrid protein |
GB8400653D0 (en) * | 1984-01-11 | 1984-02-15 | Beecham Group Plc | Conjugates |
US5174994A (en) * | 1985-11-11 | 1992-12-29 | Leuven Research & Development Vzw | Pharmaceutical composition having thrombolytic activity |
EP0266032A1 (de) * | 1986-08-29 | 1988-05-04 | Beecham Group Plc | Modifiziertes fibrinolytisches Enzym |
GB8707369D0 (en) * | 1987-03-27 | 1987-04-29 | Beecham Group Plc | Enzyme derivatives |
US5009888A (en) * | 1987-04-13 | 1991-04-23 | Genzyme Corporation | Therapeutic enzyme-antibody complexes |
GB8715302D0 (en) * | 1987-06-30 | 1987-08-05 | Ordidge R J | Nmr spectroscopy |
DK359888A (da) * | 1987-07-01 | 1989-01-02 | Beecham Group Plc | Fibrinolytisk enzym |
US5302390A (en) * | 1987-07-01 | 1994-04-12 | Beecham Group Plc | Hybrid proteins of human plasminogen and human t-PA, pharmaceutical compositions and methods of treatment |
US5256642A (en) * | 1988-04-01 | 1993-10-26 | The Johns Hopkins University | Compositions of soluble complement receptor 1 (CR1) and a thrombolytic agent, and the methods of use thereof |
US6458360B1 (en) | 1990-04-25 | 2002-10-01 | The Johns Hopkins University | Soluble complement regulatory molecules |
GB9011861D0 (en) * | 1990-05-26 | 1990-07-18 | Beecham Group Plc | Novel compounds |
GB9013345D0 (en) * | 1990-06-14 | 1990-08-08 | Beecham Group Plc | Novel compounds |
US20040072757A1 (en) * | 1990-09-04 | 2004-04-15 | Cor Therapeutics, Inc. | Agents affecting thrombosis and hemostasis |
US5597799A (en) * | 1990-09-04 | 1997-01-28 | Cor Therapeutics, Inc. | Recombinant agents affecting thrombosis |
US5583107A (en) * | 1990-09-04 | 1996-12-10 | Cor Therapeutics, Inc. | Agents affecting thrombosis and hemostasis |
WO1992018139A1 (en) * | 1991-04-09 | 1992-10-29 | Brigham And Women's Hospital | Chimeric molecule with plasminogen activator activity and affinity for atherosclerotic plaques |
GB9301289D0 (en) * | 1993-01-22 | 1993-03-17 | Smithkline Beecham Plc | Novel composition |
US5589571A (en) * | 1994-10-28 | 1996-12-31 | Cor Therapeutics, Inc. | Process for production of inhibited forms of activated blood factors |
US7544500B2 (en) | 1999-11-13 | 2009-06-09 | Talecris Biotherapeutics, Inc. | Process for the production of a reversibly inactive acidified plasmin composition |
MX2010013282A (es) | 2008-06-04 | 2010-12-21 | Talecris Biotherapeutics Inc | Composicion, metodo y kit para la preparacion de plasmina. |
PL2403865T3 (pl) | 2009-03-03 | 2016-01-29 | Grifols Therapeutics Inc | Sposoby wytwarzania plazminogenu |
US9226953B2 (en) | 2009-07-10 | 2016-01-05 | Thrombogenics Nv | Variants of plasminogen and plasmin |
WO2011023805A1 (en) | 2009-08-28 | 2011-03-03 | Thrombogenics N.V. | Use of plasmin for the treatment of filtration failure after trabeculectomy |
DK2661493T3 (en) | 2011-01-05 | 2016-07-18 | Thrombogenics Nv | PLASMINOGEN AND PLASMIN VARIANS |
KR20140064841A (ko) | 2011-08-12 | 2014-05-28 | 쓰롬보제닉스 엔.브이. | 플라스미노겐 변이체 및 플라스민 변이체 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NZ191320A (en) * | 1978-09-07 | 1982-09-14 | Beecham Group Ltd | In vivo fibrinolytic enzyme having active site blocked by hydrolytically removable group pharmaceutical compositions |
-
1979
- 1979-08-15 NZ NZ191320A patent/NZ191320A/xx unknown
- 1979-08-16 ZA ZA00794294A patent/ZA794294B/xx unknown
- 1979-08-16 CA CA333,909A patent/CA1134295A/en not_active Expired
- 1979-08-17 AU AU50046/79A patent/AU524295B2/en not_active Expired
- 1979-08-20 US US06/068,205 patent/US4285932A/en not_active Expired - Lifetime
- 1979-08-20 IL IL58079A patent/IL58079A0/xx unknown
- 1979-08-22 AR AR277800A patent/AR220575A1/es active
- 1979-08-30 EP EP79301773A patent/EP0009879B1/de not_active Expired
- 1979-08-30 DE DE7979301773T patent/DE2966301D1/de not_active Expired
- 1979-09-04 ES ES483888A patent/ES483888A0/es active Granted
- 1979-09-06 IE IE1696/79A patent/IE48478B1/en not_active IP Right Cessation
- 1979-09-06 HU HU79BE1364A patent/HU182458B/hu not_active IP Right Cessation
- 1979-09-06 DK DK373479A patent/DK160996C/da not_active IP Right Cessation
- 1979-09-07 JP JP11430579A patent/JPS5537198A/ja active Granted
-
1980
- 1980-12-16 US US06/216,799 patent/US4337244A/en not_active Expired - Lifetime
-
1985
- 1985-12-30 MY MY995/85A patent/MY8500995A/xx unknown
-
1986
- 1986-09-04 HK HK659/86A patent/HK65986A/xx not_active IP Right Cessation
-
1989
- 1989-11-24 JP JP1306342A patent/JPH02154687A/ja active Pending
-
1992
- 1992-07-13 JP JP4207007A patent/JPH05304957A/ja active Pending
-
1993
- 1993-06-24 LU LU88326C patent/LU88326I2/fr unknown
Also Published As
Publication number | Publication date |
---|---|
ES8101385A1 (es) | 1980-12-16 |
DK373479A (da) | 1980-04-11 |
EP0009879A1 (de) | 1980-04-16 |
DE2966301D1 (en) | 1983-11-17 |
HU182458B (en) | 1984-01-30 |
HK65986A (en) | 1986-09-12 |
DK160996C (da) | 1991-10-28 |
JPS5537198A (en) | 1980-03-15 |
US4337244A (en) | 1982-06-29 |
EP0009879B1 (de) | 1983-10-12 |
IE791696L (en) | 1980-03-07 |
US4285932A (en) | 1981-08-25 |
JPH0231952B2 (de) | 1990-07-17 |
NZ191320A (en) | 1982-09-14 |
MY8500995A (en) | 1985-12-31 |
AR220575A1 (es) | 1980-11-14 |
LU88326I2 (fr) | 1994-05-04 |
CA1134295A (en) | 1982-10-26 |
JPH02154687A (ja) | 1990-06-14 |
IL58079A0 (en) | 1979-12-30 |
DK160996B (da) | 1991-05-13 |
ES483888A0 (es) | 1980-12-16 |
AU5004679A (en) | 1980-03-13 |
IE48478B1 (en) | 1985-02-06 |
JPH05304957A (ja) | 1993-11-19 |
AU524295B2 (en) | 1982-09-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA794294B (en) | Enzyme derivatives for use in the treatment of venous thrombosis | |
GB2013495A (en) | Therapeutic method for the treatment of hyperlipodaemias and hyperlipoproteinaemias | |
GB2012802B (en) | Cleansing pad and method of making the same | |
PH24427A (en) | Treatment of dysmanorrhea | |
NZ183416A (en) | Composition for enzymatic treatment of cataract | |
GB2018121B (en) | Treated blood products | |
IL57596A0 (en) | Process the purification and concentration of urokinase | |
PH20118A (en) | Method for the treatment of hyperlemia | |
ZA795449B (en) | Use of rapamycin in treatment of tumors | |
JPS5786296A (en) | Treatment of polysaccharide solution | |
GB2044311B (en) | Process for the treatment of wood | |
GB1545400A (en) | Treatment of wood | |
GB2028311B (en) | Treatment of urea solution | |
PT66160A (en) | Improvements in or relating to the treatment of glass | |
GB2033865B (en) | Rotary conveyor for the treatment of goods in baths | |
JPS54141098A (en) | Menstrual blood treating article | |
GR63224B (en) | Process for the preparation of an enzym preparation riched in lipase | |
ZA792194B (en) | Treatment of liquids | |
KE3639A (en) | Enzyme derivatives for use in the treatment of venous thrombosis,compositions containing them and their preparation | |
JPS5581967A (en) | Joint treatment method | |
JPS54136576A (en) | Solution treatment | |
JPS54122315A (en) | Surface treatment | |
GB1558030A (en) | Abrasive treatment of elongate members | |
JPS54112740A (en) | Surface treatment of sliding surface | |
ZA79449B (en) | Therapeutic method for the treatment of hyperlipoproteinaemias and hyperlipodaemias |